Bausch Health Companies (BHC) Cash from Financing Activities (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Cash from Financing Activities data on file, last reported at -$100.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 31.51% year-over-year to -$100.0 million; the trailing twelve-month figure through Mar 2026 stood at -$696.0 million (down 3.26% YoY), and the FY2025 full-year result was -$742.0 million, up 14.52% from the prior year.
• Cash from Financing Activities climbed to -$100.0 million in Q1 2026, from -$235.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $1.8 billion in Q3 2023 to a low of -$719.0 million in Q3 2025.
• A 5-year average of -$41.7 million and a median of -$142.0 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 5144.44% in 2023 and plunged 376.47% in 2025, its largest moves.
• Tracing BHC's Cash from Financing Activities over 5 years: stood at -$276.0 million in 2022, then jumped by 71.38% to -$79.0 million in 2023, then surged by 207.59% to $85.0 million in 2024, then sank by 376.47% to -$235.0 million in 2025, then surged by 57.45% to -$100.0 million in 2026.
• Business Quant data shows BHC's Cash from Financing Activities at -$100.0 million in Q1 2026, -$235.0 million in Q4 2025, and -$719.0 million in Q3 2025.